Mucosolvan Gusto Frutti Di Bosco (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucosolvan Gusto Frutti Di Bosco, is a mucolytic presented as an oral liquid formulation for oral administration. It facilitates the clearance of thick bronchial secretions and is indicated for cough with tenacious sputum in acute bronchitis, chronic bronchitis and chronic obstructive pulmonary disease.

GNH USA supplies Mucosolvan Gusto Frutti Di Bosco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Ambroxol Hydrochloride is a mucolytic that acts on respiratory secretions to improve expectoration. - Acute bronchitis: reduces sputum viscosity, facilitating cough clearance. - Chronic bronchitis: helps loosen thick mucus, improving airway patency. - Chronic obstructive pulmonary disease (COPD): assists in clearing bronchial secretions, supporting breathing. - Cough with thick or tenacious sputum: promotes expectoration of mucus.

Ambroxol hydrochloride is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Taste disturbance: mild bitter or sweet taste in the mouth. - Nausea: transient feeling of queasiness. - Headache: mild to moderate headache. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or angioedema requiring medical attention. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes in rare cases.

When prescribing ambroxol hydrochloride, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust use in patients with severe kidney dysfunction. - Hepatic disease: monitor liver function in patients with existing liver conditions. - Asthma: use with caution as it may induce bronchospasm in susceptible individuals. - Pregnancy and lactation: evaluate risk‑benefit ratio before use. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Ambroxol hydrochloride may interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents: may reduce mucociliary clearance, diminishing ambroxol’s effect. - Cough suppressants (e.g., codeine): can counteract the expectorant action, leading to mucus retention.

Moderate Interactions (Monitor Closely): - Bronchodilators: concurrent use may enhance respiratory benefits but requires monitoring for additive effects. - Antibiotics (e.g., macrolides): may increase risk of gastrointestinal upset when combined. - Antihistamines: may cause additive sedation or dizziness.